Danaher
-
DHR Token Analysis: Trading Status and Platforms for DeHR Network and Danaher Tokenized Stock
In the cryptocurrency space, DHR could refer to two distinct assets: the DeHR Network token based on the BNB Chain, and DHRx, a tokenized asset representing shares of Danaher Corporation. This article will explore the current trading status, listing platforms, and relevant information for both DHR tokens, helping readers differentiate and understand how to acquire them.
-
Aristotle Capital Management's Q2 Fund Performance Lags Due to Limited Exposure to AI Infrastructure Spending Boom
The institution stated in its Q2 2026 investor letter that its value equity fund delivered a total return of 4.32% for the quarter, underperforming the Russell 1000 Value Index's gain of 13.87% and th
-
Danaher lowers full-year core revenue growth forecast to 3%-4% from previous 3%-6%; Intuitive Surgical maintains 2026 da Vinci procedure volume growth forecast at 13.5%-15.5%.
Danaher reported lower-than-expected revenue for its biotechnology business and revised its full-year core revenue growth guidance, lowering the upper end from 6% to 4% while maintaining the lower end
-
Abbott (ABT) raises full-year profit forecast, Q2 sales up 13%; Danaher (DHR) lowers full-year core revenue growth outlook, shares fall 11%
Abbott Laboratories announced strong second-quarter results for fiscal year 2026, with sales increasing by 13% year-over-year, and raised its full-year profit outlook, increasing its adjusted diluted
-
Aristotle Capital Management's Q2 Fund Performance Lags Due to Limited Exposure to AI Infrastructure Spending Boom
The institution stated in its Q2 2026 investor letter that its value equity fund delivered a total return of 4.32% for the quarter, underperforming the Russell 1000 Value Index's gain of 13.87% and th
-
Danaher lowers full-year core revenue growth forecast to 3%-4% from previous 3%-6%; Intuitive Surgical maintains 2026 da Vinci procedure volume growth forecast at 13.5%-15.5%.
Danaher reported lower-than-expected revenue for its biotechnology business and revised its full-year core revenue growth guidance, lowering the upper end from 6% to 4% while maintaining the lower end
-
Abbott (ABT) raises full-year profit forecast, Q2 sales up 13%; Danaher (DHR) lowers full-year core revenue growth outlook, shares fall 11%
Abbott Laboratories announced strong second-quarter results for fiscal year 2026, with sales increasing by 13% year-over-year, and raised its full-year profit outlook, increasing its adjusted diluted
-
DHR Token Analysis: Trading Status and Platforms for DeHR Network and Danaher Tokenized Stock
In the cryptocurrency space, DHR could refer to two distinct assets: the DeHR Network token based on the BNB Chain, and DHRx, a tokenized asset representing shares of Danaher Corporation. This article will explore the current trading status, listing platforms, and relevant information for both DHR tokens, helping readers differentiate and understand how to acquire them.
Danaher
24H Trending
-
1
Cardano (ADA) Investment Analysis: In-depth Look at Risks and Rewards
-
2
Current Status of Bitcoin Trading Platforms in Mainland China: Policy Interpretation and Risk Warning
-
3
Chilean Fixed Income Investors Flock to Inflation-Linked Notes as Nine-Month Iran War Pushes Oil to April Highs, Stoking Inflation Expectations
-
4
How Bitcoin Enters DeFi: Wrapped, Layer 2, and Native Protocol Paths
-
5
SOMM Token: Analysis of Sommelier Protocol's Value, Mechanisms, and Market Performance
-
6
The Origin of USTC and the Development History of the Terra Ecosystem
-
7
What is YCC/Yuan Chain Coin? Issue Price, Total Supply, and Investment Risk Warning
-
8
On-chain data shows Ethereum whales are actively buying, with one anonymous whale spending $62.97 million to acquire 27,553 ETH within 5 hours.
-
9
EQ9 Token: Project Positioning, Technical Status, and Market Activity Analysis
-
10
Dogecoin vs. Ethereum: A Comparative Analysis of Positioning, Technology, and Ecosystem Differences
Markets Today
Recommended Reading







